News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Stock Titan Deals and strategy
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
This article analyzes the volatility of Utah Medical Products Inc. (NASDAQ: UTMD), highlighting a strong overweight bias across all sentiment horizons. It details three distinct AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis, providing entry and exit points, targets, …
Utah Medical Products Inc. (UTMD) reported a decline in first-half 2026 financial results, with consolidated revenue falling to $8.53 million and diluted EPS to $0.84 compared to the prior year. This downturn was primarily attributed to the loss of two major customers, slower OEM …
Utah Medical Products reported a significant decline in its second-quarter FY26 financial results, with net income falling 11.9% to USD 2.69 million and net sales dropping 14.3% to USD 8.53 million. The company attributed the sales decline to the absence of sales to two …
This article from TradingKey provides an earnings forecast for Utah Medical Products Inc (UTMD), focusing on future EPS and revenue growth estimates. It includes a snapshot of the company's current stock performance, market capitalization, and P/E ratio, alongside a list of peer companies for …
Utah Medical Products (Nasdaq: UTMD) announced that its Board of Directors has approved a quarterly cash dividend of $0.31 per share of common stock. This dividend, representing a 1.6% increase over the previous year's dividend for the same quarter, is payable on October 5, …
Utah Medical Products Inc. (NASDAQ:UTMD) has announced a quarterly cash dividend of $0.31 per share of common stock, representing a 1.6% increase from the previous year's dividend. The dividend will be payable on October 5, 2026, to shareholders of record as of September 17, …
This article from Stock Traders Daily analyzes Utah Medical Products Inc. (UTMD) and its impact on rotational strategy timing. It highlights a near-term strong sentiment possibly influencing mid-term neutrality and a long-term positive bias, noting a mid-channel oscillation pattern. The analysis provides specific institutional …
Utah Medical Products, Inc. (UTMD) reported a significant year-over-year decline in Q2 2026 earnings and revenue, primarily due to the loss of two major customers. Diluted EPS decreased by 10.1% and revenues fell by 14.3%, although the company maintained solid profitability with resilient margins …
Utah Medical Products Inc (UTMD) has a current valuation score of 8.45, placing it 93rd out of 199 companies in the Healthcare Equipment & Supplies industry. Its P/E ratio is 20.98, which is slightly below its recent high but significantly above its recent low. …
This article provides a detailed cash flow statement for Utah Medical Products Inc (UTMD), covering quarterly and annual data for operating, investing, and financing activities. It presents financial figures in millions, showing year-over-year changes and absolute values for various cash flow components. The page …
Utah Medical Products Inc (UTMD) has a robust financial score of 9.29, ranking 8th in the Healthcare Equipment & Supplies industry. Despite this strong overall financial health and high operating efficiency, the company experienced a year-over-year decrease of 10.18% in its latest quarterly revenue …
This article provides a detailed historical overview of dividend payouts for Utah Medical Products Inc (UTMD), spanning the last five years. It lists various interim and final cash dividends, including their record dates, payment dates, and ex-dividend dates, along with the gross amount paid …
Utah Medical Products Inc (UTMD) has an institutional shareholding score of 7.00, placing it 78th in the Healthcare Equipment & Supplies industry. Institutional investors hold 76.75% of shares, an 8.51% increase quarter-over-quarter. The largest institutional shareholder is Bill Nygren | OAKMX, with 14.11% of …
This article provides a revenue breakdown for Utah Medical Products, Inc. (NASDAQ: UTMD). The company's primary revenue contribution came from the United States, generating $22.76 million last year, slightly down from $23.87 million the prior year. The information is presented under the financial section …
Utah Medical Products (UTMD) reported Q2 2026 revenues of $8.5 million and EPS of $0.84, with a trailing 12-month net profit margin of 29%, down from 32.3% previously. The company faces a 5.8% average annual earnings decline over five years, which challenges bullish narratives …
Utah Medical Products Inc (UTMD) shows strong fundamentals and high growth potential, despite a weak stock market performance recently. Its valuation is considered fairly valued within the Healthcare Equipment & Supplies industry. The company is in a growing phase with high and stable dividends, …
Utah Medical Products, Inc. reported weaker second-quarter results for Q2 2026, with diluted earnings of $0.84 per share on revenue of $8.5M. This represents a decline from the prior year, attributed to headwinds across its business segments. The company, specializing in niche medical devices, …
This article provides a Q2 earnings snapshot for Utah Medical. The content is explicitly minimal, containing only the title and a note about being "Powered and protected by Privacy," along with image references. No substantive financial data or details are available in the provided …
Utah Medical Products (UTMD) reported Q2 2026 consolidated net sales of $8.529 million, a 14.3% decrease year-over-year, with net income of $2.686 million. First-half sales also fell by 12.3% to $17.252 million. The decline is attributed to the loss of sales from two major …
Utah Medical Products (UTMD) announced significant declines in Q2 and 1H 2026 revenues, down 14.3% and 12.3% respectively, primarily due to zero sales to its two previously largest customers. The company now projects a 10-13% decline in 2026 sales compared to 2025, as efforts …
This article provides a detailed AI-driven analysis of Utah Medical Products Inc. (NASDAQ: UTMD), highlighting divergent sentiment across different time horizons and indicating choppy market conditions. It presents specific institutional trading strategies, including position trading, momentum breakout, and risk hedging, with defined entry, target, …
Search by ticker symbol or company name and select a result to open its chart.